Cresco Labs (CRLBF) Receivables (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Receivables came in at $38.1 million in Q1 2026, up 0.69% on a QoQ basis from $37.9 million in Q4 2025.

Cresco Labs (CRLBF) Receivables (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Receivables data on file, last reported at $38.1 million in Q1 2026.

Quarterly Receivables changed N/A year-over-year to $38.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.1 million (changed N/A YoY) and the FY2025 annual result came in at $37.9 million, changed N/A from the prior year.
Receivables improved to $38.1 million in Q1 2026, from $37.9 million in the prior quarter.
In the past five years, Receivables ranged from a high of $59.0 million in Q4 2023 to a low of $37.9 million in Q4 2025.
A 5-year average of $49.1 million and a median of $49.8 million in 2024 frame the typical range for Receivables.
The widest YoY moves for Receivables: up 37.01% in 2022, down 37.01% in 2022.
Tracing CRLBF's Receivables over 5 years: stood at $49.7 million in 2022, then gained by 18.8% to $59.0 million in 2023, then fell by 7.58% to $54.6 million in 2024, then sank by 30.56% to $37.9 million in 2025, then climbed by 0.69% to $38.1 million in 2026.
The last three Receivables figures came in at $38.1 million (Q1 2026), $37.9 million (Q4 2025), and $54.6 million (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	3.07 Bn
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn	3.49 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn	1.57 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	5.84 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	310.30 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	3.67 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	887.00 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	1.15 Bn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	1.08 Bn
10	Cresco Labs	295.09 Mn	230.98 Mn	86.95 Mn	39.88 Mn

Download Data